Long COVID-19 symptoms hitting up to 30% of patients, even those with mild acute cases
Recovering from COVID-19’s acute symptoms is only the beginning for many. From 10% to 30% of people who contract the coronavirus experience long COVID-19 symptoms for more than 12 weeks. Common post-viral long COVID-19 symptoms […]
View more
COVID-19 adding to stresses, substance use during pregnancy
As the nation’s attention turns toward the distribution of the COVID-19 vaccine, providers are seeing many pregnant patients engaging in unhealthy behaviors, such as drug and alcohol use, to cope with the stress of the […]
View more
Norton Healthcare providing Bamlanivimab for COVID-19 patients at risk of hospitalization
Norton Healthcare is making monoclonal antibody treatment Bamlanivimab available under the Food and Drug Administration’s emergency use authorization for certain patients at high risk for requiring hospitalization for COVID-19. We are fortunate to have extensive […]
View more
UK and Baptist Health Lexington, Norton Healthcare begin recruiting participants for Phase 3 COVID-19 investigational vaccine clinical trial
The University of Kentucky, in partnership with Baptist Health Lexington and Norton Healthcare in Louisville, has been selected as a testing site for the Janssen Pharmaceutical Companies of Johnson & Johnson’s Phase 3 clinical research […]
View more
All Norton Healthcare providers now can order convalescent plasma for severe or critical COVID-19 patients
Under an emergency use authorization by the Food and Drug Administration (FDA), all Norton Healthcare providers can order convalescent plasma therapy for confirmed COVID-19 hospitalized patients with severe or critical symptoms. Norton Healthcare hospitals have […]
View more
Norton Healthcare to offer COVID-19 Long-term Care Clinic for patients with lasting side effects
Norton Healthcare will launch a COVID-19 Long-term Care Clinic for adult patients who continue to experience side effects after having battled the coronavirus. “Norton Healthcare has been a regional leader in caring for patients with […]
View more
Norton Healthcare expands COVID-19 experimental treatments
As patients continue to be diagnosed with COVID-19, the disease caused by the coronavirus, Norton Healthcare is looking for ways to help them overcome the infection. Norton Healthcare is the first in the world to […]
View more
Critically ill COVID-19 patients who received convalescent plasma leaving hospital
More than 30 critically ill COVID-19 patients at Norton Healthcare have received convalescent plasma, an experimental treatment that began in mid-April. Some are still recovering, while many patients have been able to go home. Norton […]
View more
COVID-19 guidance and resources for pregnant patients
Patient safety is our top priority. Due to the COVID-19 pandemic, we have revised policies as needed to help stop the spread of infection. There have been policy changes that affect labor and delivery for […]
View more
Norton Healthcare develops protocol for prone positioning nonintubated COVID-19 patients
Norton Healthcare pulmonologists have developed a protocol for treating COVID-19 patients with prone positioning before they need to be intubated. Using the prone position is common with intubated patients with acute respiratory distress syndrome (ARDS). […]
View more
Norton Healthcare physicians first in world to test cancer drug as COVID-19 treatment
A COVID-19 patient at Norton Healthcare is the first in the world to participate in a randomized Phase 2 clinical study using low-dose selinexor. This oral drug, manufactured by Karyopharm Therapeutics Inc. and marketed as XPOVIO, is currently approved at higher doses […]
View more